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A~STRACT  Colicine V has been obtained from the culture  medium in which 
the colicinogenic bacillus E.  coli K357 L_T is grown. The material is electro- 
phorefically homogeneous and  proves to be a  lipocarbohydrate  protein  com- 
plex identical with the type-specific O  antigen of the parent bacillus. Colicine 
V  is toxic both for mice and for rabbits and readily stimulates the elaboration 
of precipitins  and bacterial agglutinins,  as well as antibodies which neutralize 
the  antibacterial  activity  of the  colicine  itself.  The  colicine  is  also  toxic  for 
certain  strains  of Enterobacteriaceae.  Although  colicine  V  and  colicine  K, 
previously described in this laboratory, have many properties in common, they 
exhibit no cross-serological  relationship  whatsoever. 
A  study of the bacteriophages has been one of Dr.  Northrop's many interests 
over the  years.  It  is  therefore  not  inappropriate  that  a  volume  of scientific 
papers  dedicated  to him should  contain  an account of the  colicines.  Phages 
and colicines bear a  remarkable resemblance to one another  (1).  Both agents 
apparently initiate  their attack upon the susceptible host by attaching  them- 
selves through  identical  receptor sites.  Furthermore,  it is known that  certain 
microorganisms  which  are  susceptible  to  both  phage  and  colicines  yield 
variants  which  are resistant  to  both  agents  (2).  Finally,  it will  be recalled, 
that in many instances  the physical and  chemical  agents which induce lyso- 
genic  bacteria  to  liberate  phage  will  frequently  induce  the  colicinogenic 
organism  to  produce  colicine  (3). 
Striking as these resemblances are it is questionable whether these relation- 
ships  are  other  than  fortuitous.  Strong  and  irrefutable  support  of this  hy- 
pothesis is found in an observation made some years ago in the writers' labora- 
tory (4).  It was shown that  colicine K  and  phage T6,  both of which exhibit 
certain  of the  similarities  which  have  been  discussed  (5),  are  entirely  un- 
related immunologically. 
Nearly  a  decade  ago  our  laboratory  undertook  the  formidable  task  of 
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isolating,  purifying,  and  characterizing the  colicines  (6).  A  perusal  of the 
literature did nothing to make easy the problem, for it was obvious that the 
chemical efforts which had been made by others toward this end were both 
fragmentary and contradictory. Gratia was the first to describe in detail an 
antibacterial  agent  which  resembled  bacteriophages  (7).  This  substance, 
which  he  named  "principle  V,"  inhibited  the  growth  of several  sensitive 
bacterial  strains.  Unlike  bacteriophages,  however,  his  agent  could  not  be 
transmitted  on  serial  passage.  Gratia  characterized this  agent,  now  known 
as colicine V, as a  filterable entity which was  heat-resistant,  dialyzable,  and 
precipitable  by  acetone. 
Following these initial observations the question of the chemical nature of 
the  colicines  remained  dormant  until  1946  when  Heatley  and  Florey  (8) 
initiated  a  chemical  study  of the  colicine  produced  by  a  strain  of E.  coli 
known as  CF1.  These investigators sent their colicinogenic strain  to  Gratia 
who stated at the time that it appeared to be identical in all respects with his 
coli V  strain which produced the "V principle." Heatley and Florey isolated 
a  substance  from  the  culture  medium  of their  microorganism  which  was 
precipitable  by alcohol and which resembled the colicine of Gratia  in  that 
it  too  was  "freely  dialyzable,"  heat-resistant,  and  sensitive  to  proteolytic 
enzymes. On the basis of these observations, they concluded that their colicine, 
like that of Gratia,  was in all probability either a  protein or a  peptide. 
Colicines  which  appeared  to  be  of high molecular weight,  because  they 
failed  to  dialyze  through  semipermeable  membranes,  were  first  isolated 
by  Halbert  (9)  and  by  Gardner.  One  of  these,  studied  by  Gardner,  was 
identified  by  Fr~d~ricq  (10)  as  colicine  V.  This  substance,  supposedly  the 
same as that of Gratia,  was not dialyzable; it was inactivated by proteolytic 
enzymes and was precipitated by both trichloroacetic and  picric acids.  The 
author  came to  the conclusion that  this  substance was  probably  a  protein. 
Little attempt was made by these investigators to establish the purity of their 
products,  nor  did  they  characterize  them  by  chemical  analyses.  This,  in 
brief,  was  the  state  of affairs  when  our  laboratory  initiated  its  studies  on 
colicine K  in  1952  (6). 
In  sum let it  be  said that  from  the culture  medium in  which a  colicine 
K-producing organism known as E. coli K235 was grown, there was obtained 
a  thermostable, non-dialyzable substance which we believed to be identical 
with colicine K  (11).  The substance was highly toxic, both for bacteria and 
mammals.  It was a  potent antigen, and elicited both precipitating and neu- 
tralizing antibodies when injected in minute quantities into rabbits. 
Highly purified colicine K  proved to be a  lipocarbohydrate-protein com- 
plex containing some 5 per cent of nitrogen,  1.5 per cent of phosphorus,  20 
per cent of lipid,  and yielded 50 per cent of reducing sugar upon hydrolysis 
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of proteolytic enzymes. Despite this,  colicine K  cannot be  called a  protein. 
Nevertheless the molecular complex can be readily dissociated into its protein 
and lipocarbohydrate components (12).  In so doing it is found that all of the 
antibacterial activity accompanies the so-called protein component, whereas 
the  lipocarbohydrate is  the  bearer  of the  mammalian  toxin  (11).  In  our 
opinion  colicine  K  is  identical  with  the  somatic  O  antigen  of the  micro- 
organism from which it is derived. 
Observations similar to ours have been made by Ntiske and his coworkers 
(13).  In  1957 these investigators purified a  colicine from a  bacillus known as 
E.  coli  SG-710.  Their colicine preparations  contained 45  to  55  per  cent of 
protein, 20 to 25 per cent of polysaccharide, 15 to 20 per cent of lipid, and 5 
to  10  per  cent of inorganic constituents and  gave but a  single broad  band 
after  paper  electrophoresis.  Both  trypsin  and  chymotrypsin destroyed  the 
antibacterial  activity of their  product.  From  the  analysis  this  colicine  too 
appeared  to be  a  lipocarbohydrate-protein complex. 
This paper will describe the isolation and properties of colicine V.  It will 
be shown that this substance, like colicine K, is  a  lipocarbohydrate-protein 
complex endowed with potent  toxic properties  for  bacteria  and  mammals. 
It will be demonstrated that, although the chemical properties of colicine V 
resemble  those  of colicine K,  the  two  bear  no  immunological relationship 
to one another. 
MATERIALS  AND  METHODS 
Strains of Microorganisms  The original colicinogenic strain used in these  studies 
was kindly sent us by Dr.  Pierre FrEd~ricq of the University of Li6ge. This bacillus, 
designated as E. coli K357, produced an antibacterial agent which he identified as 
colicine  V. When the microorganism which we received was first streaked on neo- 
peptone agar we observed  two colony types. The first of these was shiny, sticky, and 
opaque. When examined by India ink stain, the bacillus  was encapsulated. It was 
later shown to possess a  heat-labile surface or K  antigen.  In accordance with the 
Kaufmann nomenclature (14) it was designated as an L+ strain.  Since the colonies 
were opaque, the strain was termed E. coli K357 L+O, in accordance with our pre- 
vious nomenclature (4). The second variant produced dull, grainy, translucent col- 
onies  on neopeptone agar and did not possess the L  antigen; consequendy it was 
characterized as E. coli K357 L_T. 
The colicine  K-producing bacillus  used in this investigation is  a  variant of the 
strain E. coli K235 sent to us in 1952 by Fr~d~ricq.  This microorganism exists in at 
least four different forms. Two of these are encapsulated and elaborate an L antigen. 
Of these  two, one grows on neopeptone agar as translucent colonies,  and the other 
as  opaque  colonies.  The strains are designated as E.  coli K235  L+T and L+O re- 
spectively.  Two non-encapsulated or L_variants have also  been  isolated and these 
too grow as  translucent (K235  L_T)  and opaque  colonies  (K235  L_O).  It is  the x28  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  45  •  I962 
encapsulated and  opaque variant which was used in  these studies; i.e., E. coli K235 
L+O. 
In  1958  we  sent  these  four  strains  to  the  Statens  Seruminstitut  in  Copenhagen 
where they were typed. The variant E. coli  K235 L+O used here was found to have 
the serotype 01 :K1  and to be devoid of an H  antigen. We wish to express our  great 
appreciation to Dr. Fritz ~rskov for his many kindnesses throughout our work. 
In order to assay the activity of colicine V  preparations obtained during the  course 
of purification,  the  sensitive strain E.  coli ~o,  originally used by Gratia to  detect  his 
V  principle  and sent to us by Fr~d~ricq, was employed. The strain E. coli B  was used 
when  colicine  K  assays  were  performed. 
Culture  Medium  The culture medium used for growing E. coli  K357 L_T  was 
prepared so as  to contain  only dialyzable substances.  To  15 liters of 1 per cent  ca- 
samino acid medium containing 0.03 ~  phosphate at pH 7.0, was added the  sterile, 
concentrated  dialysate derived from 4  pounds  of beef heart infusion  (15).  In  addi- 
tion,  the  sterile dialysate of 25  gm of Difco yeast extract was  added.  As  an energy 
source,  300  ml of a  neutralized  30  per cent solution  of sodium lactate  and  450  ml 
of 50  per cent dextrose were employed. 
Colicine Assay  The quantitative estimation of colicine V  activity was made  by 
a ring test previously described (16). One unit of colicine V  activity has been defined 
as that amount of substance in  "r/ml which,  when placed as a  droplet  (0.02  ml) on 
the surface of nutrient  agar contained in a  Petri dish and seeded with 5  X  l0  T cells 
of E. coli ¢b, completely inhibits growth of the bacilli encompassed by the area of the 
droplet. 
Antisera  Four  different  antisera were used  in  this  study.  The  sera  of rabbits 
immunized  with  the  living  colicine  K-producing  bacillus  E.  coli  K235  L+O  were 
obtained  as  previously  described  (4).  Sera  to  the  colicine  V-producing  bacillus 
E.  coli  K357  L+O  were prepared in  a  similar manner.  Antisera  to  highly  purified 
colicine K  and  colicine  V  were  likewise  prepared  by a  procedure  described  in  an 
earlier publication  (I 1),  using as antigens electrophoretically homogeneous prepara- 
tions  of the  two colicines. 
Electrophoretic  and  Chemical  Methods  Electrophoretic  analyses  of  colicine  V 
preparations were made in the Tiselius apparatus using a  2 ml cell (17). The micro- 
analytical methods for the estimation of nitrogen, phosphorus, protein, carbohydrate, 
etc.  are the same as those used in our studies on colicine K  (11). 
Agar Diffusion Reactions  Agar diffusion tests were carried out by a  modification 
of the procedure described by Ouchterlony (18). A  piece of 1 inch adhesive tape was 
placed across one end of a microscope slide (5 X  7.5 cm). 5 ml of molten 1.5 per cent 
agar dissolved in 0.1  ~  borate buffer at pH 7.6 was placed on the slide. After solidifi- 
cation,  a  well pattern was cut using a  lucite mold and a  stainless steel cutter.  6 mm 
holes were cut and the pattern was so arranged  that the  holes were separated sym- 
metrically and in all directions  by a  distance of 8  ram,  center to center.  2  drops of 
the various solutions to be tested were placed in the wells; the slides were incubated 
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Colicine Neutralization  Tests  In order to test the ability of colicine K  and colicine 
V antisera to neutralize colicine activity, 0.3 ml of the appropriate colicine antiserum 
was added to 2.5 ml of 0.7 per cent nutrient agar at 50°C and the tube seeded with 
the test organism  (5  X  10  ~ B/ml). The soft agar was  then poured on a  Petri plate 
containing  18 ml of sterile nutrient broth-agar  (1.5 per cent). After standing for 15 
minutes  at 4°C,  0.02 ml samples  of varying concentrations of colicine were placed 
upon the surface of the agar. The plate was permitted to stand until the droplets had 
dried and was  then incubated for 6  hours  at  37°C,  and  read.  The end  point was 
considered to be the highest  dilution  of colicine which  caused complete inhibition 
of growth of the test organism. 
Toxicity  Tests  A  sterile  solution  (5  mg/ml)  of the  colicine  to  be  tested  was 
prepared in 0.9 per cent saline. A series of 1 : 1 dilutions was made and  I  rnl of each 
was injected intraperitoneally into each of 3 mice, using 20 to 22 grn animals 4  to 5 
weeks  old.  The  Collins-Nelson-Rockefeller Institute  strain  of  Swiss  mice  was  em- 
ployed. The animals were observed for 5 days and their death or survival recorded. 
Agglutination  and  Precipitin  Tests  These  tests  were  carried  out  in  the  usual 
manner.  In conducting the agglutination tests, serial dilutions of the antisera,  start- 
ing  at  1:50,  were incubated with  a  suspension  of the microorganism to  be  tested, 
containing about  1  X  109 B/ml.  Either living cells or cells which had been heated 
for  1 hour at  100°C,  in  order to reveal the somatic O  antigen  and  to destroy the 
capsular L  antigen, were employed. The tubes containing the serum and cells were 
incubated  at  370C  for 2  hours  and  the  agglutination  reactions were read  after  18 
hours at 4°C. 
In  conducting the  precipitin tests,  0.5  ml  of a  dilution  of antiserum  (2  parts  of 
serum and 3  parts of 0.9 per cent NaC1 solution) was mixed with 0.5 ml of appro- 
priate dilutions of the antigen to be tested. After 2 hours of incubation at 37°C and 
18  hours  at  4°C,  the  tubes  were  read. 
RESULTS 
Preparation  of  Colicine  V  15  liters  of  culture  medium  maintained  at 
37°C and at pH 7.0, was seeded with  1  X  105 cells ofE. coli K357 L_T grow- 
ing in the logarithmic phase.  The culture was  aerated  at the rate of 4  liters 
per minute  and  was  maintained  at  pH  7.0  by automatic  titration  with  2  M 
NasCO3  (16).  18  hours  later  growth  of the  organism  ceased  abruptly.  The 
culture was  now maintained  at pH  7.0 for 6  additional  hours  by automatic 
titration  with  2  N  HC1.  During  this  interval  there  is  a  maximal  release  of 
colicine.  The bacilli  were killed by stirring with  100 ml  of chloroform for 5 
minutes.  150 ml  of glacial  acetic  acid  was  then  added  and  the  bacilli  were 
removed  by  centrifugation.  The  centrifugate,  containing  some  400  units  of 
colicine  per  ml,  was  reduced  in  vacuo  at  18°C  to  a  volume  of  1  liter.  The 
solution  was  now  dialyzed  against  distilled  water  at  4°C  for  24  hours.  The 
material  was  reconcentrated,  redialyzed,  and  then  dried  from  the  frozen 
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designated "crude colicine  V." The activity of the  preparation  is,  as a  rule, 
very high.  0.02  ml  of a  solution,  containing  1.5  to  3  "r/ml,  completely  in- 
hibited the growth of the test organism E. coli~ when using the ring test (16). 
The crude colicine V  was further  purified  by fractional  precipitation  with 
ethyl alcohol.  Cold ethanol was added to a  1 per cent solution of the colicine 
in 0.02 M sodium acetate at 0°C to bring the final concentration of alcohol to 
30 per cent.  After standing  for  1 hour  at 0°C  a  small  amount  of precipitate 
was centrifuged off and discarded.  Sufficient ethanol was now added to bring 
the  final  concentration  to  60  per  cent  and  the  precipitated  colicine  was 
separated  by  centrifugation.  Approximately  75  per  cent  of  the  starting 
material  was recovered.  The inactive pigmented  supernatant  was discarded. 
The  precipitate  was  now dissolved in  water  and  dialyzed  overnight  at  4°C 
and  then freeze-dried.  This material,  "purified  colicine V," was obtained  as 
a  crumbly,  slightly  grayish  white  product.  Alcohol  precipitation  serves  to 
remove most of the pigment from the preparations,  but the procedure must 
be carried  out with  dispatch  and  at  low temperature to  avoid a  significant 
loss in activity. 
Although  the  colicine obtained  at  this juncture  is electrophoretieally  and 
serologically  homogeneous,  it  is  still  pigmented,  possibly because of a  con- 
taminant  from  the  culture  medium.  This  can  be successfully eliminated  in 
the following manner. 
4  gm of 200 mesh DEAE  cellulose was washed on a  sintered  glass funnel 
four times with 200 ml of 0.3 M tris buffer, containing 0.5 M NaC1 at pH 7.2. 
The  material  was  then  washed  thoroughly  with  0.05  M tris  at  pH  8.0.  A 
slurry  was  made  in  the  0.05  M buffer  and  the  cellulose  was  poured  into  a 
column  1.9 cm in  diameter.  The  material  was finally compressed  to form  a 
column  10 cm in height.  1.65 gm of the alcohol-precipitated  colicine V  was 
dissolved in  100 rnl  of 0.05 M tris at pH 8.0.  The solution was placed on the 
column,  and  permitted  to flow through  by gravity.  The column was washed 
with 200 ml of the same buffer in order to wash through the colicine. A  small 
pigmented  band  of material  about  2  to  3  mm  thick  remained  adherent 
to the cellulose at the very top of the column. After dialysis at 4°C the colicine 
was  recovered  from  the  solution  by freeze-drying.  1.31  gm  was  recovered. 
This  procedure  resulted  in  no  loss  in  specific  activity. 
Properties of Colicine V  Crude colicine V  and the purified substance show 
only slight  differences in their  physical  and  chemical properties.  The proce- 
dure  employed  for  the  purification  of the  colicine  results  primarily  in  the 
elimination of pigment.  The purified product is soluble in water and gives an 
opalescent  solution.  Its  biological activity is such that  0.02  ml  of a  solution 
containing  1 to 2 ~,/ml completely inhibits the growth of E. coli 9 when spotted 
on a  colicine assay plate seeded with 5  X  107 bacilli.  This corresponds to an 
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Chemical  Properties  Colicine  V  appears  to  be  typical  of  the  lipocar- 
bohydrate-protein complexes, or O  antigens, found in many enteric bacilli. 
The substance contains 3.8 per cent of nitrogen and 2.0 per cent of phosphorus, 
and on acid hydrolysis (1  N H2SO4  at  100°C  for 5  hours)  it yields some 43 
per cent of reducing sugars calculated as glucose. An insoluble residue appears 
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FmURE 1.  Absorption curve of co!icine V. A  =  absorbance of a solution of colicine 
V containing 0.5 mg per ml in tris buffer at pH 8.0. 
on hydrolysis,--a lipid which is  soluble in chloroform and which comprises 
some  11.3  per  cent by weight of the original lipocarbohydrate-protein com- 
plex.  Colicine V  gives both strong biuret and Folin tests,  as well as a  strong 
positive anthrone test. The Folin-positive material (calculated as serum albu- 
min)  amounted to  10.4 per cent. The anthrone-positive material (calculated 
as glucose) was 20.6 per cent. Colicine V  shows absorption in the ultraviolet 
region,  and  a  typical spectrum is  given in Fig.  1,  where it is  seen that the 
colicine is  not contaminated with any appreciable quantity of nucleic acid. 
Colicine V  is not precipitated either by picric or trichloroacetic acids nor by 
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We  have  not  attempted  to  dissociate  the  complex  with  phenol  by  the 
procedure of Morgan (12), nor have any attempts been made to characterize 
the carbohydrate or the other components of the colicine. As with colicine K, 
the  antibacterial  activity of  colicine  V  is  readily destroyed  by  crystalline 
trypsin.  Purified colicine V,  obtained by the procedure described  above,  is 
electrophoretically homogeneous. A  solution of the colicine in 0.1  M sodium 
borate at pH 9.20 showed but a  single symmetrical peak after 10,300 seconds 
of electrophoresis as shown in Fig. 2. The calculated mobility was minus 4.16 
)<  l0 -5  cm2/volt  sec. 
Toxicity  of  Colicine  V  Colicine  V  exhibits  marked  toxicity  both  for 
mice and for rabbits.  1 ml of a  sterile solution of colicine V,  containing 1.25 
FIGUm~ 2.  Electrophoretic pattern of colicine V.  1, ascending boundary of a solution 
of colicine V in 0.1  M borate buffer at pH 9.2  (concentration 5 mg/ml)  after 10,300 
seconds. 2, descending boundary. 
mg/ml, when injected intraperitoneally into young 4 to 5 week old mice of the 
Collins-Nelson-Rockefeller Institute strain  of Swiss  mice,  killed  all  animals 
as  can  be  seen  in  Table  I. 
When rabbits were given an intradermal dose of 1 mg of the colicine dis- 
solved  in  0.2  ml  of saline,  a  marked  local  and  systemic reaction  occurred 
within 24 hours. The animals suffered malaise, a marked rise in temperature, 
and  a  severe  reaction  at  the  site  of injection,  which  was  accompanied  by 
edema and  an area of central necrosis. 
The Immunological Properties of the Colicinogenic Bacilli E. coli K235 and K357 
The  colicine  V-producing  bacillus  E.  coli  K357  is  an  exceedingly labile 
organism from the point of view of its progeny and their antigenic makeup. 
We have isolated at least six different colonial forms from the strain which 
was originally sent us and we have ascertained their ability to produce colicine 
V.  Of the six,  two were set aside for further study.  One  of these  produced 
large,  mucoid,  and  opaque  colonies when plated on neopeptone agar.  This JOHN J.  HUTTON AND  WALTHEP-. F.  GOEBEL  Isolation of golidne  V  I33 
variant  was  encapsulated  when  examined  by  an  India  ink  stain  and  was 
therefore designated as E.  coli K357  L+O, because the colonies were opaque 
(O) and because the bacillus had a thermolabile (L) antigen. 
The  other  colicinogenic  variant  grew  as  flat,  rough,  and  translucent 
colonies, which agglutinated spontaneously in the antiserum of rabbits  im- 
munized with the L+O bacillus. The unencapsulated bacillus was designated 
E. coli K357 L_T. Both variants elaborated appreciable quantities of colicine 
V  when grown in liquid culture  (400  to 800  units/ml).  It will be recalled 
(16)  that the colicine K-producing bacillus E.  coli K235, sent us some years 
ago by Frdd~ricq, also yielded a  variety of colonial forrrLs. 
Our work on colicine K, and now that on colicine V, has revealed that the 
two  highly purified colicines which we  have isolated  are  in aU probability 
TABLE  I 
TOXICITY OF  COLICINE V  IN MICE 
Colicinc  injcctecl,  rag. 
5.0  2.5  1,25  0.62 
D~4 D~4 D~4  Ds4 D24 Ds4  Ds4 D24 D48  S S S 
D  -- death (subscript denotes hours survival after  injection of  material). 
S -- survival. 
identical with the type-specific O  antigens of the respective organisms. Since 
these substances are both lipocarbohydrate-protein complexes and since they 
are so similar in chemical properties, it was of interest to ascertain whether 
tl~e two strains of bacilli themselves might not be serologically related. 
For the purpose of this study sera of rabbits immunized with the encapsu- 
lated L+O forms of the two colicine-producing bacilli were used. In addition, 
the sera of rabbits which had been injected with the two highly purified and 
electrophoretically homogeneous colicines themselves were also studied. The 
results of the agglutination tests in the antibacterial sera are given in Table 
II.  It may be  seen that,  at  the  dilutions tested,  the  encapsulated colicine 
V-producing bacillus failed to  agglutinate in its  homologous antiserum,  as 
one might expect.  Only after the microorganism had been heated at  100°C 
for an hour in order to destroy its capsular or L  antigen, did it indeed ag- 
glutinate. This agglutination is, of course, due to the interaction of the type- 
specific O  antibody and the bacterial O  antigen, which is revealed only after 
the  thermolabile  L  antigen  is  removed  by  the  boiling  process.  The  non- 
encapsulated L_T  variant,  however,  agglutinated spontaneously.  It  should 
be  noted  that  neither  the  unheated  nor  the  heated  colicine K-producing 
bacillus E.  coli K235  L+O agglutinated in the immune serum elicited by the 
colicine V  microorganism. I34  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  45  "  I952 
A  reciprocal relationship is seen to exist with respect to the colicine K- 
producing bacillus E.  coli  K235  L+O  and  its antiserum.  Here  the  micro- 
organism showed some slight agglutination in homologous antiserum due to 
the interaction of the capsular L  antigen and its antibody. After heating, the 
organism agglutinated  readily.  There  is  no  cross-reaction,  however,  of the 
colicine  V-producing organism in  the  K  antiserum.  Thus,  a  study of the 
agglutination  reactions  of  these  two  colicine-producing  bacilli  indicates 
TABLE  II 
AGGLUTINATION  OF  E.  COLI K357  L+O  AND 
L_T  (COLICINE V) AND OF E.  COLI K235 L+O  (COLICINE K) 
IN  A~ITIBACTERIAL  SERA 
Serum No.  Animal  immunized 
with E. Cdi  Test antlgcn E.  Coli 
Final dilution of antiserum 
1:I00 1:2001:400 1:800 I:1600 1:3200 1:6400 
28  K357 L+O 
(colicine  V) 
131  K235 L+O 
(colicine  K) 
K357 L+O  0  0  0  0  0  0  0 
K357 L+O boiled  4  4  3  2  I  ~  0 
K357 L_T  4  4  4  4  4  I  1/~ 
K235 L+O  0  0  0  0  0  0  0 
K235 L+O boiled  0  0  0  0  0  0  0 
K357 L+O  0  0  0  0  0  0  0 
K357 L+O boiled  0  0  0  0  0  0  0 
K357 L_T  0  0  0  0  0  0  0 
K235 L+O  2  1  0  0  0  0  0 
K235 L+O boiled  3  4  4  3  2  1  0 
E.  ¢oli  K235 L+O  =  encapsulated (L+)  form of the colicine K-producing bacillus. 
E.  ¢oli  K357 L+O  =  encapsulated (L+)  form of the colieine V-producing bacillus. 
E.  ¢oli  K357 L_T  =  non-encapsulated (L+)  form of the  colicine  V-producing bacillus. 
4  =  complete agglutination with clear supernate. 
1 =  slight agglutination. 
0  =  no agglutination. 
clearly  and  unequivocally that  neither  the  capsular  L  nor  the somatic  O 
antigens  (i.e.  the colicines) of the two bacteria are serologically related. 
If one examines the agglutination reactions of the two colicinogenic bacilli 
in antisera elicited by the two colicines, it is again clearly evident (Table III) 
that the antibodies evoked by the two purified preparations are also highly 
specific. Although colicine V antiserum agglutinates both the heated encapsu- 
lated form of E.  coli K357 and the unencapsulated L_T variant it is without 
effect upon the colicine K-producing microorganism, E. coli K235. Similarly, 
the colicine K  antiserum agglutinates only the homologous bacillus, and does 
not  cross-react  with  the  heterologous  colicine  V-producing  strain.  These 
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ship tO one another and that the two colicines derived from the two different 
strains  of E.  coli  are  also  serologically  unrelated. 
Precipitation  Reactions of Colicines V and K  in Antisera  The specificity of the 
agglutination  reactions of  the two different  strains  of  colicinogenic  bacilli 
is paralleled by the specificity of precipitation reactions of the two chemically 
purified colicines V  and  K.  When these substances  are tested in  their own 
antisera  and  in  the  sera  of rabbits  immunized with  the  two  colicinogenic 
bacilli, it will again be seen that there is no serological crossing (Table IV). 
TABLE  III 
AGGLUTINATION  OF  E.  COL1  K357  L+O  AND  L_T 
(COLICINE V) AND OF E.  COLI  K235  L+O (COLICINE K) 
IN  COLICINE ANTISERA 
Serum No. 
Final dilution of antiserum 
Rabbit immunized  --~  ~  ~  ~  ~  ~  ~ 
with  Test antigen g.  Goli  d2  _  d2  --  d2  d2 
14  Colieine 
V 
17  Colieine 
K 
K357 L+O  0  0  0  0  0  0  0 
K357 L+O boiled  4  3  3  3  3  2  1 
K357 L_T  4  4  4  4  4  2  1 
K235 L+O  0  0  0  0  0  0  0 
K235 L+O boiled  0  0  0  0  0  0  0 
K357 L+O  0  0  0  0  0  0  0 
K357 L+O boiled  0  0  0  0  0  0  0 
K357  L_T  0  0  0  0  0  0  0 
K235 L+O  0  0  0  0  0  0  0 
K235 L+O boiled  3  4  4  3  2  1  0 
From the table it is evident that colicine V precipitates only in the antiserum 
of rabbits  immunized with  the  colicine  V-producing  bacillus  or  with  the 
purified colicine V itself. It does not cross-react in the heterologous K  antisera. 
Similarly, colicine K  reacts only in those antisera in which the colicine K- 
producing organism served as the antigen or in which colicine K  itself was 
used  as  the immunizing agent.  Thus  it may be  concluded that  colicine K 
and colicine V  are immunologically unrelated as are the two strains of bacilli 
from which the colicines were derived. When the two colicines were tested 
by the agar diffusion technique using antibacterial sera (Fig.  3), it could be 
seen that each colicine produced but a  single band and reacted only with its 
homologous antibody.  Here again  are no discernible cross-reactions. 
Neutralization  of Colicines  V  and K  by  Antiserum  Our  previous work has 
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antibodies which both precipitate  and neutralize  the antibacterial  properties 
of the  colicine  (4).  In  order  to  determine  whether  antisera  to  colicine  V 
behave similarly,  or whether the two different colicine antisera neutralize the 
activity of the heterologous colicine, the following experiment was performed. 
0.3  ml  of colicine K  antiserum  was added  to  a  tube containing  2.5 ml  of 
nutrient broth and 0.5 per cent agar at 50 °C. To a second tube was added 0.3 
ml of colicine V  antiserum  and  to a  third  control  tube was added 0.3 ml  of 
TABLE  IV 
PRECIPITATION  REACTIONS  OF 
COLICINES  V  AND  K  IN ANTIBACTERIAL SERA 
AND  IN  COLICINE  ANTISERA 
Final  serum  dilution 
Serum  ~  --  e~ 
No,  Rabbit  immunized  with  Test antigen  ,~  ,~  '" 
28  E. coli K357 L+O  Colicine V  ++++  +++  ++  + 
Colieine K  0  0  0  0 
14  Colieine V  Colicine V  ++++  ++-k+  ++q-  + 
Colicine K  0  0  0  0 
131  g. ¢oli K235 L+O  Colicine V  0  0  0  0 
Colicine K  ++-4-  +++  +++  + 
17  Colicine K  Colicine V  0  0  0  0 
Colicine K  ++  +++  ++  + 
++++  =  heavy disk-like precipitate. 
-k  =  slight precipitate. 
0  =  no precipitate. 
sterile saline.  The tubes were now seeded with 5  X  107 bacilli of a  culture of 
E.  coli B. Three similar tubes were prepared  and seeded with 5  X  107 bacilli 
of a  culture of E. coli ~,. The six tubes were now poured  upon nutrient  broth- 
agar  (1.5  per  cent)  plates.  After  standing  at  4°C  for  15  minutes  the  first 
three plates were spotted with 0.02 ml samples of solutions of decreasing  con- 
centrations of colicine K  starting at 20 -r/ml. The remaining three plates, those 
seeded with E. coli ~o, were spotted with solutions of decreasing  concentrations 
of colicine V.  After standing  for 30 minutes at room temperature,  the plates 
were incubated at 37 °C for 6 hours.  They were then removed and observed. 
The results  of this  experiment  are presented  in  their  entirety in  Table  V. 
A  photograph of this experiment,  without the control plates, is also presented 
in Fig.  4.  From the table it will  be seen that  the inhibition  of growth of the 
test organism E.  coli B by colicine K  is marked indeed  (control tube) and that JOHN J.  HUTTON AND  I]VALTHER F.  GOEBEL  isolation of Coiicine V  1;$! 
0.02  ml  of a  solution  containing  1.25 7  still  caused complete inhibition of 
growth. On the plate on which colicine K  antiserum had been incorporated 
there was no inhibitory action of the colicine (Table V  and Fig.  4A).  The 
latter had been completely neutralized by the antiserum and hence there was 
uniform growth of the test organism over the entire area of the plate.  The 
plate in which colicine V antiserum had been incorporated, however, showed 
marked inhibition of growth of the test organism by the colicine K  (Fig.  4B). 
This fact indicates that colicine V  antiserum was without effect upon colicine 
K; i.e., the colicine is not neutralized by the heterologous colicine V antiserum. 
An identical pattern was observed when colicine V  was  tested on plates 
Flotn~  3.  Agar diffusion reactions  of colicines  V  and K.  1,  colicine K  1 mg/ml.  2, 
colicine V  1 mg/ml. 3, antiserum to colicine K-producing organism E. coli K235 L+O. 
4,  antiserum  to colicine V-producing organism E.  coli  K357  L+O. 
seeded with E. coli ~. The colicine itself (control tube) inhibited the growth of 
the test bacillus again at a concentration of 1.25 ~/ml (Table V).  Colicine V 
antiserum, on the other hand, completely neutralized the antibacterial activity 
of the  colicine  (Fig.  4C),  whereas colicine K  antiserum was without effect 
(Fig. 4D). This experiment reveals the fact that the antisera to colicine V and 
to  colicine  K  both  contain  neutralizing  antibodies.  These  antibodies  are 
highly specific,  however, and they neutralize only the homologous colicine. 
A photograph of this experiment, not including control plates, is presented in 
Fig. 4. 
DISCUSSION 
At the time we began our work on colicine V we were fortunate in procur- 
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coli,  all  of which  elaborated  the  colicine  in  which  we  were  interested.  In 
addition,  we had  on hand the original  colicine V-producing strain of Gratia, 
sent  us  some  years  ago  by  Dr.  Fr~d~ricq.  All  these  strains  were  carefully 
screened for their  ability to elaborate colicine V  in  the culture medium used 
in  these  studies,  but  only one  strain,  E.  coli  K357,  did  so in  any  promising 
quantity.  From  this  bacillus  were  obtained  six  variants  which  differed  in 
colonial form  and  of these,  two elaborated  some 400 to 800  units  of colicine 
V  when  grown  under  rigorously  controlled  conditions  of  pH  and  in  the 
medium  described.  The  L_T  variant  was  selected  tbr  study  rather  than 
TABLE  V 
NEUTRALIZATION  OF  ANTIBACTERIAL  ACTIVITY  OF 
COLICINES  V  AND  K  BY  HOMOLOGOUS  ANTISERA 
Colicine used in test, 3' 
Plate No.  Antibacterial serum added  Collcine  tested  20  10  5  2.5  1.25  0.6 
1  Colicine K  0  0  0  0  0  0 
2  Colicine  V  Colicine  K  4  4  4  4  4  2~ 
3  None  (control)  4  4  4  4  4  2 
4  Coliclne V  0  0  0  0  0  0 
5  Colicine K  Colicine V  4  4  4  4  4  3 
6  None  (control)  4  4  4  4  4  21~ 
Plates  1, 2, 3 seeded with test organism E. coli B. 
Plates 4, 5, 6 seeded with test organism E.  coli ¢. 
4  =  complete inhibition of growth of test organism. 
2  =  partial inhibition of growth of test organism. 
0  =  no  inhibition  of  growth  of  test  organism  indicating  complete neutralization of colicine 
activity. 
the  L+O  bacillus,  largely  because  the  use  of  this  strain  would  obviate  the 
necessity  of  separating  any  L  antigen  from  the  colicine  during  the  proc- 
ess  of purification.  That  this  was  a  happy  choice  is  obvious,  because  the 
ultimate  isolation  of a  highly  purified  preparation  of colicine  V  presented 
no  untoward  difficulty.  The  product  which  was  eventually  obtained  ex- 
hibited  both  electrophoretic  and  serological  homogeneity.  Its  chemical 
analysis,  which  resembled  that  of colicine  K,  characterized  the  substance 
unequivocally as a lipocarbohydrate-protein complex which exhibited toxicity 
both for mammals  and  for bacteria.  Our studies on colicine  V  have  not yet 
included an investigation of the components of the complex.  Yet there is little 
reason to believe that such a  study would not reveal that this O  antigen,  like 
others  of the  Enterobacleriaceae,  would yield its  so-called  protein  and  lipocar- 
bohydrate constituents upon dissociation with phenol. 
Colicine  V  is  a  potent  antigen  as  our  investigations  have  shown,  for  not JOHN J.  HUTTON AND WALTHER F.  GOEBEL  Isolation  of Colicine  V  I39 
FIGURE 4.  Inhibition of antibacterial activity of colicines V  and K  by homologous 
antisera. A and B, plates seeded with E.  coil B and spotted with colicine K.  C  and D, 
plates seeded with E.  coli d~ and spotted with colicine V. 
The soft agar of plates A  and D  contains 0.3  ml of colicine K  antibacterial serum. 
The soft agar of plates B and C contains 0.3 ml of colicine V  antibacterial serum. Note 
that the activity of the two colicines on their respective hosts  is inhibited only by the 
homologous antibacterial serum. 14  o  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  45  "  1962 
only does it  give rise  to  specific bacterial  agglutinins  and  precipitins  in  the 
sera of immunized rabbits,  but,  like colicine K,  it also stimulates antibodies 
which neutralize  the  antibacterial  properties  of the  colicine.  We  find  it  of 
considerable interest that the immune sera elicited by both the colicinogenie 
bacillus E.  coli K357 and the purified colicine itself show no serological cross- 
reactions with the microorganism from which colicine K  is obtained, or with 
the purified colicine K. 
There is  one observation which we  have not been able  to reconcile with 
those of earlier investigators,  namely the fact that  colicine V  was found by 
them to be readily diffusible through semipermeable membranes and we did 
not.  We  have  no  evidence whatsoever that  the  colicine  V  which  we  have 
prepared will dialyze through cellophane membranes, manufactured by the 
Visking Co.  (Chicago),  be  they "seamless cellulose tubing,  thin walled,"  or 
for "dialysis."  It is  not impossible that the porosity of the cellophane which 
was used in Europe two or three decades ago differed from that of the cello- 
phane which is  manufactured today. All this is unfortunately a  discrepancy 
for which we have no explanation.  The fact remains that colicine V  is  now 
the third  of the colicines to  be well characterized, and,  like colicine K  and 
the colicine of Nfiske, colicine V  appears to be a  high molecular weight lipo- 
carbohydrate-protein complex which is  identical with  the  O  antigen  of the 
bacillus from which it was obtained. 
The work presented in this communication was supported  in part by a grant from the Department 
of Health,  Education  and  Welfare,  United  States  Public  Health  Service,  National  Institutes  of 
Health, Bethesda. 
REFERENCES 
1.  FRI~DI~.RICQ, P.,  Syrup. Soc. Exp.  Biol.,  1958, 12,  104. 
2.  FR~D~.RmQ, P.,  and GRATIA, A., Compt. rend. soc. Biol.,  1949, 143,  560. 
3.  FR~DtRICQ, P.,  Compt. rend. soc. Biol.,  1954, 148, 1276. HAMON, Y.,  and LEWE, 
Z.  V.,  Ann.  Inst.  Pasteur,  1955, 89,  336. 
4.  AMANO, T.,  GO~.BEL, W. F.,  and SMmTH, E.  M.,  J.  Exp.  Med.,  1958, 108,  731. 
5.  FR~D~RmQ, P.,  Schweiz Z.  allg.  Path.  Bact.,  1950, 20,  670. 
6.  GOEBEL, W. F., BARRY, G. T., JESAITIS, M. A., and MILLER, E. M., Nature,  1955, 
176,  700. 
7.  GRATIA,  A., Compt. rend. soc. Biol.,  1925, 93,  1040. GRATIA, A., Ann.  Inst.  Pasteur, 
1932, 48,413. 
8.  HEATta~Y, N.  G., and FLOREY, H. W.,  Brit.  J.  Exp.  Path.,  1946, 27, 378. 
9.  HALBERT, S.  P.,  and MACNUSON, H. J.,  ft.  Immunol.,  1948, 58,  397. 
10.  GARDNER, J. F., Brit. J. Exp. Path.,  1950, 31,  102. 
11.  GOEBEL, W. F., and BARRY, G. T., J. Exp. Med.,  1958, 107,  185. 
12.  MORCAN, W. T. J.,  and PARTmDCE, S.  M., Biochem.  J.,  1941, 35,  1140. 
13.  NiSSKP., R., H6SEL, G., VENNER, H., and ZINNER, H., Biochem. Z.,  1957, 329,346. JOHN J.  HUTTON AND WALTHER. F.  GOEBEL  Isolation  of Colicine  V  I4I 
14.  KAUFMANN, F.,  Enterobacteriaceae,  Copenhagen,  Ejnar  Munksgaard,  2nd 
edition,  1954, 161. 
15.  Doi~, V. P., Proc. Soc. Exp. Biol. and Med.,  1946, 63, 122. 
16.  GO~.BF-L, W. F., Ba~tgv, G. T.,  and SaeDLOVSRV,  T.,  J.  Exp.  Med.,  1956, 103, 
577. 
17.  LONOSWORTH, L. G., Anal.  Chem., 1953, 25,  1074. 
18.  OUCHTZRLONY,  O., Ark. Kemi, Mineral. och Geol. 1949, B26, 1. 